(+31)71 - 332 28 70


VitroScan participates in multiple research collaborations and grant consortia. A clinical trial program is initiated in collaboration with (academic) medical centers for selected solid cancers, including ovarian cancer, pancreatic cancer, and mesothelioma.

Drug developers

Our platform enables in-depth drug sensitivity evaluation of drug candidates in series of patients: In Vitro Clinical Trials.

  • Co-culture Tumor & TIL's Early characterization of responsive subgroup
  • Identification of predictive biomarkers
  • Correlation with genetic markers
  • Benchmark against standard of care drugs
  • Refine Market Access proposition

Research institutes

VitroScan performs advanced functional testing using tumor samples to evaluate the sensitivity of registered and novel drug therapies including chemotherapy, small molecules, antibodies, ADC’s, immuno-oncology.

Home > Pipeline